​

Intuitive Surgical (ISRG) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

ISRG Stock Forecast

Intuitive Surgical (ISRG) stock forecast, based on 52 Wall Street analysts, predicts a 12-month average price target of $590.33, with a high of $605.00 and a low of $566.00. This represents a 19.05% increase from the last price of $495.86.

$300 $370 $440 $510 $580 $650 High: $605 Avg: $590.33 Low: $566 Last Closed Price: $495.86

ISRG Stock Rating

Intuitive Surgical stock's rating consensus is Buy, based on 52 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 37 Buy (71.15%), 10 Hold (19.23%), 5 Sell (9.62%), and 0 Strong Sell (0.00%).

Buy
Total 52 0 5 10 37 Strong Sell Sell Hold Buy Strong Buy

ISRG Price Target Upside V Benchmarks

TypeNameUpside
StockIntuitive Surgical19.05%
SectorHealthcare Stocks 18.80%
IndustryMedical Instruments & Supplies Stocks21.66%
IdeaArtificial Intelligence Stocks List2.21%

Price Target Trends

1M3M12M
# Anlaysts1120
Avg Price Target$566.00$566.00$554.85
Last Closing Price$495.86$495.86$495.86
Upside/Downside14.15%14.15%11.90%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jul, 2581491133
Jun, 25814101-33
May, 258149-132
Apr, 2581410-133
Mar, 25814101-33
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jul 14, 2025Ryan ZimmermanBTIG$566.00$519.898.87%14.15%
Apr 14, 2025Ryan ZimmermanBTIG$560.00$490.1314.26%12.94%
Mar 18, 2025Robert W. Baird$600.00$483.9523.98%21.00%
Mar 17, 2025Truist Financial$605.00$488.8023.77%22.01%
Dec 18, 2024Richard NewitterTruist Financial$640.00$526.4721.56%29.07%
Dec 02, 2024Patrick WoodMorgan Stanley$650.00$541.9319.94%31.09%
Oct 18, 2024David RomanGoldman Sachs$604.00$517.9716.61%21.81%
Oct 18, 2024Shagun SinghRBC Capital$555.00$473.7317.16%11.93%
Oct 18, 2024Adam MaederPiper Sandler$538.00$473.7313.57%8.50%
Oct 18, 2024Anthony PetroneMizuho Securities$550.00$473.7316.10%10.92%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jul 14, 2025BTIGBuyBuyhold
Jun 09, 2025Deutsche BankHoldSelldowngrade
May 22, 2025CitigroupBuyBuyhold
Apr 23, 2025Piper SandlerOverweightOverweighthold
Apr 14, 2025BTIGBuyBuyhold
Jan 29, 2025UBSOverweightOverweighthold
Jan 24, 2025CitigroupBuyBuyhold
Jan 16, 2025Morgan StanleyOverweightOverweighthold
Jan 08, 2025BernsteinOutperformOutperformhold
Jan 01, 2025CICCMarket Performinitialise

Financial Forecast

EPS Forecast

$0 $3 $6 $9 $12 $15 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$3.02$4.79$3.72$5.12$6.54-----
Avg Forecast$3.24$4.96$4.67$5.60$6.91$8.05$9.45$10.99$12.00$14.01
High Forecast$3.32$5.09$4.79$5.65$7.02$8.23$10.07$11.12$12.74$14.88
Low Forecast$3.14$4.82$4.56$5.52$6.80$7.79$8.70$10.87$11.49$13.42
Surprise %-6.79%-3.43%-20.34%-8.57%-5.35%-----

Revenue Forecast

$0 $4B $8B $12B $16B $20B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$4.36B$5.71B$6.22B$7.12B$8.35B-----
Avg Forecast$4.28B$5.68B$6.25B$7.08B$8.19B$9.57B$11.08B$12.77B$14.02B$15.79B
High Forecast$4.37B$5.79B$6.37B$7.42B$8.58B$9.69B$11.43B$12.80B$14.69B$16.55B
Low Forecast$4.19B$5.56B$6.13B$6.86B$7.93B$9.44B$10.63B$12.74B$13.57B$15.28B
Surprise %1.74%0.47%-0.39%0.57%1.98%-----

Net Income Forecast

$500M $2B $3B $4B $5B $6B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$1.06B$1.70B$1.32B$1.80B$2.32B-----
Avg Forecast$860.04M$1.29B$1.54B$1.80B$2.47B$2.86B$3.36B$3.93B$4.29B$5.01B
High Forecast$1.03B$1.55B$1.85B$2.16B$2.51B$2.94B$3.60B$3.97B$4.55B$5.32B
Low Forecast$688.03M$1.03B$1.23B$1.44B$2.43B$2.78B$3.11B$3.88B$4.11B$4.80B
Surprise %23.32%31.93%-14.10%--6.01%-----

ISRG Forecast FAQ

Is Intuitive Surgical stock a buy?

Intuitive Surgical stock has a consensus rating of Buy, based on 52 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 37 Buy, 10 Hold, 5 Sell, and 0 Strong Sell, reflecting a consensus that Intuitive Surgical is a favorable investment for most analysts.

What is Intuitive Surgical's price target?

Intuitive Surgical's price target, set by 52 Wall Street analysts, averages $590.33 over the next 12 months. The price target range spans from $566 at the low end to $605 at the high end, suggesting a potential 19.05% change from the previous closing price of $495.86.

How does Intuitive Surgical stock forecast compare to its benchmarks?

Intuitive Surgical's stock forecast shows a 19.05% upside, outperforming the average forecast for the healthcare stocks sector (18.80%) and underperforming the medical instruments & supplies stocks industry (21.66%), leading the artificial intelligence stocks list (2.21%) investment idea.

What is the breakdown of analyst ratings for Intuitive Surgical over the past three months?

  • July 2025: 24.24% Strong Buy, 42.42% Buy, 27.27% Hold, 3.03% Sell, 3.03% Strong Sell.
  • June 2025: 24.24% Strong Buy, 42.42% Buy, 30.30% Hold, 3.03% Sell, 0% Strong Sell.
  • May 2025: 25.00% Strong Buy, 43.75% Buy, 28.12% Hold, 0% Sell, 3.12% Strong Sell.

What is Intuitive Surgical’s EPS forecast?

Intuitive Surgical's average annual EPS forecast for its fiscal year ending in December 2025 is $8.05, marking a 23.09% increase from the reported $6.54 in 2024. Estimates for the following years are $9.45 in 2026, $10.99 in 2027, $12 in 2028, and $14.01 in 2029.

What is Intuitive Surgical’s revenue forecast?

Intuitive Surgical's average annual revenue forecast for its fiscal year ending in December 2025 is $9.57B, reflecting a 14.64% increase from the reported $8.35B in 2024. The forecast for 2026 is $11.08B, followed by $12.77B for 2027, $14.02B for 2028, and $15.79B for 2029.

What is Intuitive Surgical’s net income forecast?

Intuitive Surgical's net income forecast for the fiscal year ending in December 2025 stands at $2.86B, representing an 23.22% increase from the reported $2.32B in 2024. Projections indicate $3.36B in 2026, $3.93B in 2027, $4.29B in 2028, and $5.01B in 2029.